ADM, US0394831020

ADM stock gains 2.80 percent as amino acid venture takes shape

Published on 10/05/2026 at 19:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

ADM stock traded at USD 82.70 on October 5, 2026, while Q2 adjusted EPS reached USD 1.84 against a USD 1.49 estimate. Eight analysts hold a Hold consensus.

Schwarz-Weiß-Reportage von Erntehelfern auf einem Getreidefeld mit Mähdrescher
Archer-Daniels-Midland US0394831020 dokumentiert Feldarbeiter bei der Weizenernte mit Mähdreschern im dramatischen Schwarzweiß-Stil, Illustration mit AI erstellt.

ADM stock (ISIN US0394831020) was trading at USD 82.70 on the NYSE on October 5, 2026 at 1:16 p.m. ET, up 2.80 percent, as investors weighed a stronger second-quarter earnings performance and a new amino acid venture. Simply Wall St reported on October 3, 2026 that ADM and CJ CheilJedang agreed to form a joint venture for feed-grade amino acids across North and South America.

Q2 earnings beat the estimate

ADM generated USD 22.681 billion in revenue in Q2 2026, while diluted earnings per share reached USD 1.84. According to MarketBeat, the EPS result exceeded the USD 1.49 consensus estimate by USD 0.35, although revenue came in below the USD 22.75 billion estimate.

The earnings comparison is the central financial signal: ADM's Q2 adjusted EPS was USD 1.84, compared with USD 0.92 in Q2 2025. Operating profit reached USD 978 million in the quarter, up from USD 319 million in Q1 2026, giving the recovery a measurable sequential step.

Guidance and amino acids expand the story

ADM raised its adjusted EPS guidance for fiscal 2026 to USD 5.15-5.60 from USD 4.15-4.70, according to Simply Wall St. The range puts the next phase of the investment case on earnings execution rather than on revenue expansion alone.

The CJ CheilJedang agreement adds a strategic counterweight to ADM's cyclical commodity exposure. CJ is the majority owner, while ADM contributes its Decatur, Illinois, facility and regional manufacturing and sales capabilities, according to Simply Wall St.

Analysts see limited upside

The analyst consensus remains Hold. MarketBeat says eight analysts set an average twelve-month price target of USD 79.67, with a low of USD 63.00 and a high of USD 95.00.

That spread shows why the venture matters for valuation: the market is already pricing ADM near the middle of the target range, so further gains depend on converting the earnings recovery and new nutrition-related capacity into durable cash generation.

ADM stock trades below its yearly high

ADM stock was trading at USD 82.70 on the NYSE on October 5, 2026 at 1:16 p.m. ET, up 2.80 percent. The same session's volume was 1,302,633 shares, and the 52-week range was USD 55.58 to USD 88.75.

ADM stock facts

  • Company: Archer-Daniels-Midland Company
  • ISIN: US0394831020
  • Ticker: ADM
  • Trading venue: NYSE
  • Price (as of October 5, 2026, 1:16 p.m. ET): USD 82.70
  • Market capitalization: USD 39.9 billion (as of October 5, 2026)
  • 52-week range: USD 55.58-88.75 (as of October 5, 2026)
  • Sector / Industry: Consumer Defensive / Agricultural Farm Products
  • Volume: 1,302,633 shares (as of October 5, 2026)

Upcoming dates for ADM stock

  • October 27, 2026: Q3 2026 earnings report

More news and analyses on ADM stock

Disclaimer...

en | US0394831020 | ADM | boerse | 70235441 | bgmi